Literature DB >> 22378815

Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women.

Ellen W Freeman1, Mary D Sammel, Hui Lin, Clarisa R Gracia.   

Abstract

CONTEXT: Anti-mullerian hormone (AMH) has emerged as a marker of ovarian reserve and a possible surrogate measure of reproductive aging.
OBJECTIVE: The aim of the study was to evaluate the predictive value of AMH levels in determining the median time to menopause for late reproductive age women and the predictive ability of AMH compared to FSH and inhibin b. DESIGN AND
SETTING: A 14-yr follow-up in the Penn Ovarian Aging Study, 1996-2010, was conducted for a randomly identified population-based cohort.
SUBJECTS: A total of 401 late reproductive age women participated in the study. MAIN OUTCOME MEASURE: Observed time to menopause was measured.
RESULTS: All participants were premenopausal, with a mean (SD) age of 41.47 (3.52) yr and a median AMH level of 0.68 ng/ml at baseline. AMH strongly predicted time to menopause; age further improved predictions. Among women with a baseline AMH level below 0.20 ng/ml, the median time to menopause was 5.99 yr [95% confidence interval (CI), 4.20-6.33] in the 45- to 48-yr age group and 9.94 yr (95% CI, 3.31-12.73) in the 35- to 39-yr age group. With higher baseline AMH levels above 1.50 ng/ml, the median time to menopause was 6.23 yr in the oldest age group and more than 13.01 yr in the youngest age group. Smoking significantly reduced the time to menopause (hazard ratio, 1.61; 95% CI, 1.19-2.19; P = 0.002). AMH was a stronger predictor of time to menopause than FSH or inhibin b.
CONCLUSIONS: AMH is a strong predictor of median time to menopause in late reproductive age women. Age and smoking are significant and independent contributors to the predictions of AMH.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22378815      PMCID: PMC3339896          DOI: 10.1210/jc.2011-3032

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  36 in total

Review 1.  Anti-Müllerian hormone: clinical insights into a promising biomarker of ovarian follicular status.

Authors:  Estelle Feyereisen; Daniel H Méndez Lozano; Joëlle Taieb; Laetitia Hesters; René Frydman; Renato Fanchin
Journal:  Reprod Biomed Online       Date:  2006-06       Impact factor: 3.828

2.  Relationship of serum antimüllerian hormone concentration to age at menopause.

Authors:  J van Disseldorp; M J Faddy; A P N Themmen; F H de Jong; P H M Peeters; Y T van der Schouw; F J M Broekmans
Journal:  J Clin Endocrinol Metab       Date:  2008-03-11       Impact factor: 5.958

3.  Earlier age at menopause, work, and tobacco smoke exposure.

Authors:  Lora E Fleming; Silvina Levis; William G LeBlanc; Noella A Dietz; Kristopher L Arheart; James D Wilkinson; John Clark; Berrin Serdar; Evelyn P Davila; David J Lee
Journal:  Menopause       Date:  2008 Nov-Dec       Impact factor: 2.953

4.  Prospective study of the determinants of age at menopause.

Authors:  J T Bromberger; K A Matthews; L H Kuller; R R Wing; E N Meilahn; P Plantinga
Journal:  Am J Epidemiol       Date:  1997-01-15       Impact factor: 4.897

5.  Adiponectin induces periovulatory changes in ovarian follicular cells.

Authors:  Sandra Ledoux; Danila B Campos; Flavia L Lopes; Mira Dobias-Goff; Marie-France Palin; Bruce D Murphy
Journal:  Endocrinology       Date:  2006-08-17       Impact factor: 4.736

6.  Graphical methods for assessing violations of the proportional hazards assumption in Cox regression.

Authors:  K R Hess
Journal:  Stat Med       Date:  1995-08-15       Impact factor: 2.373

7.  Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study.

Authors:  Ilse A J van Rooij; Frank J M Broekmans; Gabrielle J Scheffer; Caspar W N Looman; J Dik F Habbema; Frank H de Jong; Bart J C M Fauser; Axel P N Themmen; Egbert R te Velde
Journal:  Fertil Steril       Date:  2005-04       Impact factor: 7.329

8.  Association of anti-mullerian hormone levels with obesity in late reproductive-age women.

Authors:  Ellen W Freeman; Clarisa R Gracia; Mary D Sammel; Hui Lin; Lony Chong-Leong Lim; Jerome F Strauss
Journal:  Fertil Steril       Date:  2006-11-15       Impact factor: 7.329

9.  Body size affects measures of ovarian reserve in late reproductive age women.

Authors:  H Irene Su; Mary D Sammel; Ellen W Freeman; Hui Lin; Tracey DeBlasis; Clarisa R Gracia
Journal:  Menopause       Date:  2008 Sep-Oct       Impact factor: 2.953

10.  Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition.

Authors:  MaryFran R Sowers; Aimee D Eyvazzadeh; Daniel McConnell; Matheos Yosef; Mary L Jannausch; Daowen Zhang; Sioban Harlow; John F Randolph
Journal:  J Clin Endocrinol Metab       Date:  2008-07-01       Impact factor: 5.958

View more
  88 in total

1.  The original Beckman Coulter Generation II assay significantly underestimates AMH levels compared with the revised protocol.

Authors:  Michael Bonifacio; Cara K Bradley; Sonal Karia; Mark Livingstone; Mark C Bowman; Steven J McArthur
Journal:  J Assist Reprod Genet       Date:  2015-10-14       Impact factor: 3.412

Review 2.  Endocrinology of the Menopause.

Authors:  Janet E Hall
Journal:  Endocrinol Metab Clin North Am       Date:  2015-09       Impact factor: 4.741

3.  Anti-Müllerian hormone concentrations in premenopausal women and breast cancer risk.

Authors:  Hazel B Nichols; Donna D Baird; Frank Z Stanczyk; Anne Z Steiner; Melissa A Troester; Kristina W Whitworth; Dale P Sandler
Journal:  Cancer Prev Res (Phila)       Date:  2015-04-14

4.  Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts.

Authors:  Wenzhen Ge; Tess V Clendenen; Yelena Afanasyeva; Karen L Koenig; Claudia Agnoli; Louise A Brinton; Joanne F Dorgan; A Heather Eliassen; Roni T Falk; Göran Hallmans; Susan E Hankinson; Judith Hoffman-Bolton; Timothy J Key; Vittorio Krogh; Hazel B Nichols; Dale P Sandler; Minouk J Schoemaker; Patrick M Sluss; Malin Sund; Anthony J Swerdlow; Kala Visvanathan; Mengling Liu; Anne Zeleniuch-Jacquotte
Journal:  Int J Cancer       Date:  2018-02-08       Impact factor: 7.396

5.  Anti-Müllerian hormone, follicle stimulating hormone, antral follicle count, and risk of menopause within 5 years.

Authors:  Catherine Kim; James C Slaughter; Erica T Wang; Duke Appiah; Pamela Schreiner; Benjamin Leader; Ronit Calderon-Margalit; Barbara Sternfeld; David Siscovick; Melissa Wellons
Journal:  Maturitas       Date:  2017-05-01       Impact factor: 4.342

6.  Anti-Müllerian hormone levels and incidence of early natural menopause in a prospective study.

Authors:  Elizabeth R Bertone-Johnson; JoAnn E Manson; Alexandra C Purdue-Smithe; Anne Z Steiner; A Heather Eliassen; Susan E Hankinson; Bernard A Rosner; Brian W Whitcomb
Journal:  Hum Reprod       Date:  2018-06-01       Impact factor: 6.918

7.  Impact of breast cancer on anti-mullerian hormone levels in young women.

Authors:  H I Su; S W Flatt; L Natarajan; A DeMichele; A Z Steiner
Journal:  Breast Cancer Res Treat       Date:  2012-12-09       Impact factor: 4.872

8.  Antimüllerian hormone and antral follicle count are lower in female cancer survivors and healthy women taking hormonal contraception.

Authors:  Lauren N C Johnson; Mary D Sammel; Katherine E Dillon; Lara Lechtenberg; Allison Schanne; Clarisa R Gracia
Journal:  Fertil Steril       Date:  2014-06-14       Impact factor: 7.329

9.  Early Life Body Fatness, Serum Anti-Müllerian Hormone, and Breast Density in Young Adult Women.

Authors:  Kimberly A Bertrand; Heather J Baer; E John Orav; Catherine Klifa; Ajay Kumar; Nola M Hylton; Erin S LeBlanc; Linda G Snetselaar; Linda Van Horn; Joanne F Dorgan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-05-09       Impact factor: 4.254

10.  Predicting the timeline to the final menstrual period: the study of women's health across the nation.

Authors:  Gail A Greendale; Shinya Ishii; Mei-Hua Huang; Arun S Karlamangla
Journal:  J Clin Endocrinol Metab       Date:  2013-03-26       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.